OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel: Oxford, UK Wednesday, November 12, 2025, 17:00 Hrs [IST] Oxford Gene Technology (OGT), a Sysmex ...

Title: GB3226, A Novel, Orally Active, First-in-Class Small Molecule Inhibitor of ENL-Yeats and FLT3 Kinase for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia Presenting Author: Louis ...

Detailed price information for Astellas Pharma Inc (ALPMF) from The Globe and Mail including charting and trades.

Patients with newly diagnosed acute myeloid leukemia (AML) now have access to oral decitabine/cedazuridine combinations that ...

An Iranian knowledge-based company has successfully developed “Midovens,” a domestically produced anti-cancer drug that ...

Damora Therapeutics, the sixth company launched based on assets developed by Paragon Therapeutics, is advancing a portfolio of anti-mutant calreticulin (mutCALR) targeted therapies, led by DMR-001, a ...

Panelists discuss how emerging therapies like menin inhibitors show promise based on strong preclinical data and clinical responses, while CD47 inhibitors have faced setbacks in phase 3 trials, with ...

Promising Phase 1 clinical data for CLN-049, a FLT3xCD3 bispecific T cell engager, demonstrating ~30% CRc rate in heavily pretreated, all-comer ...

Curis, Inc. , a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its financial and operating ...

Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...

The Toxic Mutation was added to Grow a Garden on August 30, 2025, as part of the Fairy Event update. It's a mutation that's tied to a pet, so here's everything you need to know about this mutation.

The Corrosive Mutation was added to Grow a Garden on August 30, 2025, before the Fairy Event update. It's a mutation that requires combining two different ones to make it, so here's everything you ...